Legacy Emanuel Medical Center is a hospital located in the Eliot neighborhood of Portland, Oregon, United States. Founded in 1912, it is one of only two Level I trauma centers in the state of Oregon, and home to the only burn center between Seattle and Sacramento.

There are 554 beds in Legacy Emanuel Hospital and Health Center.

During the past decade, Legacy Emanuel Hospital and Health Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 89 clinical trials were completed, i.e. on average, 556.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 23 clinical trials were completed. i.e. 328.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Legacy Emanuel Hospital and Health Center" #1 sponsor was "Children's Oncology Group" with 88 trials, followed by "National Cancer Institute (NCI)" with 33 trials sponsored, "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored and "Legacy Health System" with 6 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Legacy Emanuel Hospital and Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 133 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator and "NRG Oncology" with 5 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Legacy Emanuel Hospital and Health Center" are "Leukemia" (17 trials), "Breast Cancer" (15 trials), "Lymphoma" (14 trials), "Sarcoma" (12 trials) and "Acute Lymphoblastic Leukemia" (7 trials). Many other conditions were trialed in "Legacy Emanuel Hospital and Health Center" in a lesser frequency.

Most popular intervention types in "Legacy Emanuel Hospital and Health Center" are "Drug" (145 trials), "Other" (75 trials), "Biological" (65 trials), "Radiation" (47 trials) and "Procedure" (34 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (44 trials), "cyclophosphamide" (35 trials), "etoposide" (26 trials), "filgrastim" (23 trials) and "vincristine sulfate" (23 trials). Other intervention names were less common.

The vast majority of trials in "Legacy Emanuel Hospital and Health Center" are 167 trials for "All" genders, 21 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Legacy Emanuel Hospital and Health Center". undefined are not yet recruiting, 7 are recruiting, 41 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 135 completed trials in Legacy Emanuel Hospital and Health Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Legacy Emanuel Hospital and Health Center, 7 "Phase 1" clinical trials were conducted, 61 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".